Lisinopril Dihydrate is the dihydrate form of lisinopril, a synthetic peptide derivative and orally active angiotensin-converting enzyme inhibitor, commonly known as an ACE inhibitor. It belongs to the antihypertensive class of active pharmaceutical ingredients and is widely associated with cardiovascular pharmaceutical formulations.
Lisinopril inhibits angiotensin-converting enzyme and reduces the conversion of angiotensin I into angiotensin II. Reduction of angiotensin II activity is associated with decreased vasoconstrictor activity and reduced aldosterone secretion.
Lisinopril Dihydrate is associated with pharmaceutical formulations developed for hypertension, heart failure, and cardiovascular therapeutic applications. It is also used in regulated pharmaceutical research, formulation development, analytical studies, and cardiovascular drug development programs.
Lisinopril Dihydrate API requires stringent control of identity, assay, purity, related substances, water content, residual solvents, elemental impurities, and other critical quality parameters. The hydration state and water content are important quality considerations for maintaining consistent API specifications.
Swapnroop Drugs and Pharmaceuticals supports Lisinopril Dihydrate API sourcing and pharmaceutical raw material requirements for pharmaceutical companies, formulation developers, research organizations, laboratories, and international buyers. Product specifications and documentation are supplied according to applicable customer, regulatory, and project requirements.
Lisinopril Dihydrate API is associated with:
Available documentation may include, subject to product and supply requirements:
Certificate of Analysis – COA
Material Safety Data Sheet – MSDS / SDS
Product Specification Sheet
Analytical Test Report
HPLC Purity Data, where available
Water Content Information
Residual Solvent Information
Elemental Impurity Information, where applicable
Storage and Handling Information
Stability Information, where available
Regulatory and technical documentation, subject to agreement
Swapnroop Drugs and Pharmaceuticals is a pharmaceutical raw material supplier based in Maharashtra, India, serving pharmaceutical, research, and development requirements.
We focus on:
Swapnroop Drugs and Pharmaceuticals supplies and supports Lisinopril Dihydrate API requirements for pharmaceutical companies, cardiovascular formulation developers, research organizations, laboratories, and international buyers.
For Lisinopril Dihydrate API requirements, customers may contact our team for product availability, specifications, documentation, quantity, packaging, storage conditions, and commercial information.
Company Name: Swapnroop Drugs and Pharmaceuticals
Location: Maharashtra, India
Email: enquiry@sdp.org.in
Website: www.sdp.org.in